Promacta 50 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCX6E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,496
Award facts
- Contract value 100% obligated
- $18,496.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,496.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Promacta 50 mg tablets, with a completion date of January 27, 2026. This non-set-aside contract was competitively awarded on January 5, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Promacta (eltrombopag) is an oral thrombopoietin receptor agonist used to treat thrombocytopenia in military and veteran populations, representing part of the Defense Health Agency's pharmaceutical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026 that provides global pharmaceutical support for military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains for Defense Department and veteran healthcare programs. The company's selection demonstrates its capability to meet federal procurement requirements through open competition and reflects its significant role in supporting the military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCX6E?
SPE2DR26FCX6E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FCX6E worth?
The government has obligated $18,496 on SPE2DR26FCX6E.
Is contract SPE2DR26FCX6E an order under another contract?
Yes. SPE2DR26FCX6E is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCX6E competed?
The extent of competition for SPE2DR26FCX6E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award